Patents by Inventor Vasudeva Prahlada Rao

Vasudeva Prahlada Rao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11795418
    Abstract: The present invention relates to endoglucanase variants and methods for obtaining endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: June 9, 2021
    Date of Patent: October 24, 2023
    Assignee: Novozymes A/S
    Inventors: Jens Erik Nielsen, Lars Anderson, Allan Svendsen, Rune Nygaard Monrad, Lars Giger, Vasudeva Prahlada Rao, Sohel Dalal, Santhosh Vasu Mepadam, Marie Thrysoe Kruse, Kasper D. Rand, Pernille F. Jensen
  • Patent number: 11525128
    Abstract: The present invention relates to endoglucanase variants and methods for obtaining endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: December 13, 2022
    Assignee: Novozymes A/S
    Inventors: Rune Nygaard Monrad, Vasudeva Prahlada Rao, Rajendra Kulothungan Sainathan, Sohel Dalal, VSanthosh Vasu Mepadam, Allan Svendsen, Mette Louise Dissing Overgaard, Lars Andersen, Geetha Hiremath Mendez
  • Patent number: 11359188
    Abstract: The present invention relates to xanthan lyase variants and methods for obtaining xanthan lyase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: June 14, 2022
    Assignee: Novozymes A/S
    Inventors: Rune Nygaard Monrad, Rajendra Kulothungan Sainathan, Geetha Hiremath Mendez, Sohel Dalal, Shilpi Agarwal, Allan Svendsen, Mette Louise Dissing Overgaard, Vasudeva Prahlada Rao
  • Patent number: 11326153
    Abstract: The present invention relates to alpha-amylase variants comprising a substitution at a position corresponding to position 188 and at least one further substitution at a position corresponding to position 242 or 279 or 275 of SEQ ID NO: 1, in particular one or more combinations of substitutions selected from the group consisting of E188P+S242Y, E188P+S242F, E188P+S242H, E188P+S242W, E188P+S242P, E188P+S242I, E188P+S242T, E188P+S242L, E188P+K279W, E188P+K279Y, E188P+K279F, E188P+K279H, E188P+K279I, E188P+K279L, E188P+K279D, E188P+K279M, E188P+K279S, E188P+K279T E188P+K279N, E188P+K279Q, E188P+K279V, E188P+K279A, E188P+N275F, E188P+N275Y, E188P+N275W, and E188P+N275H, wherein the variant has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to a parent alpha amylase selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO:
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: May 10, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Vasudeva Prahlada Rao, Rakhi Saikia, Vivek Srivastava, Kendra Darlene Stallings
  • Publication number: 20220089979
    Abstract: The present invention relates to endoglucanase variants and methods for obtaining endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: June 9, 2021
    Publication date: March 24, 2022
    Applicant: Novozymes A/S
    Inventors: Jens Erik Nielsen, Lars Anderson, Allan Svendsen, Rune Nygaard Monrad, Lars Giger, Vasudeva Prahlada Rao, Sohel Dalal, Santhosh Vasu Mepadam, Marie Thrysoe Kruse, Kasper D. Rand, Pernille F. Jensen
  • Patent number: 11203790
    Abstract: The present invention relates to glucoamylase variants, polynucleotides encoding the variants, methods of producing the variants, and methods of using the variants. Also described are the use of glucoamylases of the invention for starch conversion to produce fermentation products, such as ethanol, and syrups, such as glucose. The invention also relates to a composition comprising a glucoamylase variant of the invention.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: December 21, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Shikha Gupta, Allan Svendsen, Vivek Srivastava, Marco Malten, Thomas Agersten Poulsen, Preethi Ramaiya, Beth Nelson, Vasudeva Prahlada Rao, Padmavathi Balumuri
  • Patent number: 11072765
    Abstract: The present invention relates to endoglucanase variants and methods for obtaining endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: July 27, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Jens Erik Nielsen, Lars Anderson, Allan Svendsen, Rune Nygaard Monrad, Lars Giger, Vasudeva Prahlada Rao, Sohel Dalal, Santhosh Vasu Mepadam, Marie Thrysoe Kruse, Kasper D. Rand, Pernille F. Jensen
  • Publication number: 20210189364
    Abstract: The present invention relates to alpha-amylase variants comprising a substitution at a position corresponding to position 188 and at least one further substitution at a position corresponding to position 242 or 279 or 275 of SEQ ID NO: 1, in particular one or more combinations of substitutions selected from the group consisting of E188P+S242Y, E188P+S242F, E188P+S242H, E188P+S242W, E188P+S242P, E188P+S242I, E188P+S242T, E188P+S242L, E188P+K279W, E188P+K279Y, E188P+K279F, E188P+K279H, E188P+K279I, E188P+K279L, E188P+K279D, E188P+K279M, E188P+K279S, E188P+K279T E188P+K279N, E188P+K279Q, E188P+K279V, E188P+K279A, E188P+N275F, E188P+N275Y, E188P+N275W, and E188P+N275H, wherein the variant has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to a parent alpha amylase selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO:
    Type: Application
    Filed: December 7, 2018
    Publication date: June 24, 2021
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Vasudeva Prahlada Rao, Rakhi Saikia, Vivek Srivastava, Kendra Darlene Stallings
  • Publication number: 20210155915
    Abstract: The present invention relates to xanthan lyase variants and methods for obtaining xanthan lyase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: August 3, 2018
    Publication date: May 27, 2021
    Applicant: Novozymes A/S
    Inventors: Rune Nygaard Monrad, Rajendra Kulothungan Sainathan, Geetha Hiremath Mendez, Sohel Dalal, Shilpi Agarwal, Allan Svendsen, Mette Louise Dissing Overgaard, Vasudeva Prahlada Rao
  • Publication number: 20210155916
    Abstract: The present invention relates to endoglucanase variants and methods for obtaining endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: August 3, 2018
    Publication date: May 27, 2021
    Applicant: Novozymes A/S
    Inventors: Rune Nygaard Monrad, Vasudeva Prahlada Rao, Rajendra Kulothungan Sainathan, Sohel Dalal, VSanthosh Vasu Mepadam, Allan Svendsen, Mette Louise Dissing Overgaard, Lars Andersen, Geetha Hiremath Mendez
  • Publication number: 20200140965
    Abstract: The present invention relates to glucoamylase variants having an increase in specific activity and/or an increase in melting temperature measured by TSA of at least 0.5 degrees Celsius, and further wherein the variants have at least at least 85%, at least 90%, at least 95% identity, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100%, sequence identity to the amino acid sequence of SEQ ID NO: 3. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: October 18, 2019
    Publication date: May 7, 2020
    Applicant: NOVOZYMES A/S
    Inventors: Shikha Gupta, Allan Svendsen, Vivek Srivastava, Marco Malten, Thomas Agersten Poulsen, Preethi Ramaiya, Beth Nelson, Vasudeva Prahlada Rao, Padmavathi Balumuri
  • Publication number: 20190218478
    Abstract: The present invention relates to endoglucanase variants and methods for obtaining endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: August 24, 2017
    Publication date: July 18, 2019
    Applicant: NOVOZYMES A/S
    Inventors: Jens Erik Nielsen, Lars Anderson, Allan Svendsen, Rune Nygaard Monrad, Lars Giger, Vasudeva Prahlada Rao, Sohel Dalal, Santhosh Vasu Mepadam, Marie Thrysoe Kruse, Kasper D. Rand, Pernille F. Jensen